25 XP   0   0   10

Genoway
Buy, Hold or Sell?

Let's analyse Genoway together

PenkeI guess you are interested in Genoway. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Genoway. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Genoway

I send you an email if I find something interesting about Genoway.

Quick analysis of Genoway (30 sec.)










What can you expect buying and holding a share of Genoway? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
€1.80
Expected worth in 1 year
€1.92
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
€0.12
Return On Investment
2.9%

For what price can you sell your share?

Current Price per Share
€4.16
Expected price per share
€3.51 - €4.91
How sure are you?
50%

1. Valuation of Genoway (5 min.)




Live pricePrice per Share (EOD)

€4.16

2. Growth of Genoway (5 min.)




Is Genoway growing?

Current yearPrevious yearGrowGrow %
How rich?$17m$15.8m$847.1k5.1%

How much money is Genoway making?

Current yearPrevious yearGrowGrow %
Making money$742.9k$314.1k$428.8k57.7%
Net Profit Margin5.3%2.9%--

How much money comes from the company's main activities?

3. Financial Health of Genoway (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#606 / 1007

Most Revenue
#217 / 1007

Most Profit
#137 / 1007

Most Efficient
#127 / 1007

What can you expect buying and holding a share of Genoway? (5 min.)

Welcome investor! Genoway's management wants to use your money to grow the business. In return you get a share of Genoway.

What can you expect buying and holding a share of Genoway?

First you should know what it really means to hold a share of Genoway. And how you can make/lose money.

Speculation

The Price per Share of Genoway is €4.16. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Genoway.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Genoway, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €1.80. Based on the TTM, the Book Value Change Per Share is €0.03 per quarter. Based on the YOY, the Book Value Change Per Share is €0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Genoway.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.071.6%0.061.5%0.030.7%0.000.0%0.010.3%
Usd Book Value Change Per Share0.000.0%0.030.8%0.010.3%0.051.2%0.040.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.030.8%0.010.3%0.051.2%0.040.8%
Usd Price Per Share4.94-4.37-3.80-3.21-2.66-
Price to Earnings Ratio18.48-17.18-54.25-63.46-146.47-
Price-to-Total Gains Ratio43.19--67.90-678.20-10,987.66-
Price to Book Ratio2.56-2.31-2.11-2.24-2.59-
Price-to-Total Gains Ratio43.19--67.90-678.20-10,987.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.464512
Number of shares223
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.030.05
Usd Total Gains Per Share0.030.05
Gains per Quarter (223 shares)7.2411.05
Gains per Year (223 shares)28.9644.20
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10291904434
20584808878
3087770133122
401161060177166
501451350221210
601741640265254
702031930309298
802322220354342
902612510398386
1002902800442430

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.00.00.0100.0%8.02.00.080.0%12.06.00.066.7%32.06.00.084.2%49.010.07.074.2%
Book Value Change Per Share1.00.02.033.3%3.02.05.030.0%6.04.08.033.3%19.010.09.050.0%32.019.015.048.5%
Dividend per Share0.00.03.00.0%0.00.010.00.0%0.00.018.00.0%0.00.038.00.0%0.00.066.00.0%
Total Gains per Share1.00.02.033.3%3.02.05.030.0%6.04.08.033.3%19.010.09.050.0%32.019.015.048.5%

Fundamentals of Genoway

About Genoway

genOway Société anonyme, a biotechnology company, engages in the development and commercialization of custom genetically modified mouse, rat, and cell line models worldwide. It produces customized mouse models, such as knockout (KO) and knockin (KI) mouse models; customized rat models, including constitutive and conditional KO, point mutation KI, and quick KI rat models; and customized cell lines, such as constitutive and inducible KO, point mutation KI, reporter KI, quick KI, and KI cell lines. The company also offers humanized immune checkpoint mouse models; immunodeficient and reconstituted mouse and rat strains models; humanized immune target models; other mouse and rat catalog models; and cell lines. It serves pharmaceutical and life science companies, and academic institutes. The company was incorporated in 1999 and is based in Lyon, France.

Fundamental data was last updated by Penke on 2024-04-30 22:20:06.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Genoway.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Genoway earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Genoway to the Biotechnology industry mean.
  • A Net Profit Margin of 5.1% means that €0.05 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Genoway:

  • The MRQ is 5.1%. The company is making a profit. +1
  • The TTM is 5.3%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ5.1%TTM5.3%-0.2%
TTM5.3%YOY2.9%+2.4%
TTM5.3%5Y-1.1%+6.4%
5Y-1.1%10Y2.1%-3.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1%-207.2%+212.3%
TTM5.3%-216.8%+222.1%
YOY2.9%-282.4%+285.3%
5Y-1.1%-426.4%+425.3%
10Y2.1%-589.3%+591.4%
1.1.2. Return on Assets

Shows how efficient Genoway is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Genoway to the Biotechnology industry mean.
  • 1.7% Return on Assets means that Genoway generated €0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Genoway:

  • The MRQ is 1.7%. Using its assets, the company is less efficient in making profit.
  • The TTM is 2.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ1.7%TTM2.1%-0.4%
TTM2.1%YOY0.9%+1.2%
TTM2.1%5Y0.0%+2.1%
5Y0.0%10Y0.5%-0.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7%-13.0%+14.7%
TTM2.1%-12.5%+14.6%
YOY0.9%-11.2%+12.1%
5Y0.0%-13.6%+13.6%
10Y0.5%-15.2%+15.7%
1.1.3. Return on Equity

Shows how efficient Genoway is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Genoway to the Biotechnology industry mean.
  • 3.7% Return on Equity means Genoway generated €0.04 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Genoway:

  • The MRQ is 3.7%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.8%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ3.7%TTM4.8%-1.1%
TTM4.8%YOY2.1%+2.7%
TTM4.8%5Y-0.3%+5.1%
5Y-0.3%10Y1.0%-1.3%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.7%-16.6%+20.3%
TTM4.8%-15.7%+20.5%
YOY2.1%-14.2%+16.3%
5Y-0.3%-18.9%+18.6%
10Y1.0%-19.9%+20.9%

1.2. Operating Efficiency of Genoway.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Genoway is operating .

  • Measures how much profit Genoway makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Genoway to the Biotechnology industry mean.
  • An Operating Margin of -66.6% means the company generated €-0.67  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Genoway:

  • The MRQ is -66.6%. The company is operating very inefficient. -2
  • The TTM is -25.4%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-66.6%TTM-25.4%-41.2%
TTM-25.4%YOY-9.2%-16.2%
TTM-25.4%5Y-7.3%-18.1%
5Y-7.3%10Y-3.6%-3.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-66.6%-285.4%+218.8%
TTM-25.4%-226.2%+200.8%
YOY-9.2%-288.4%+279.2%
5Y-7.3%-469.6%+462.3%
10Y-3.6%-599.3%+595.7%
1.2.2. Operating Ratio

Measures how efficient Genoway is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.66 means that the operating costs are €1.66 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Genoway:

  • The MRQ is 1.661. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.919. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.661TTM0.919+0.742
TTM0.919YOY0.758+0.161
TTM0.9195Y0.366+0.553
5Y0.36610Y0.556-0.190
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6613.231-1.570
TTM0.9193.303-2.384
YOY0.7583.763-3.005
5Y0.3665.586-5.220
10Y0.5567.464-6.908

1.3. Liquidity of Genoway.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Genoway is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.00 means the company has €0.00 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Genoway:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.518-1.518
TTM1.518YOY2.339-0.821
TTM1.5185Y1.941-0.423
5Y1.94110Y1.604+0.337
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.855-3.855
TTM1.5184.160-2.642
YOY2.3395.323-2.984
5Y1.9416.122-4.181
10Y1.6046.480-4.876
1.3.2. Quick Ratio

Measures if Genoway is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Genoway to the Biotechnology industry mean.
  • A Quick Ratio of 0.00 means the company can pay off €0.00 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Genoway:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.288-1.288
TTM1.288YOY1.908-0.619
TTM1.2885Y1.482-0.194
5Y1.48210Y1.244+0.238
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.506-3.506
TTM1.2884.001-2.713
YOY1.9085.390-3.482
5Y1.4826.127-4.645
10Y1.2446.488-5.244

1.4. Solvency of Genoway.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Genoway assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Genoway to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.51 means that Genoway assets are financed with 50.9% credit (debt) and the remaining percentage (100% - 50.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Genoway:

  • The MRQ is 0.509. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.519. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.509TTM0.519-0.010
TTM0.519YOY0.540-0.021
TTM0.5195Y0.597-0.078
5Y0.59710Y0.575+0.022
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5090.344+0.165
TTM0.5190.339+0.180
YOY0.5400.275+0.265
5Y0.5970.368+0.229
10Y0.5750.389+0.186
1.4.2. Debt to Equity Ratio

Measures if Genoway is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Genoway to the Biotechnology industry mean.
  • A Debt to Equity ratio of 112.0% means that company has €1.12 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Genoway:

  • The MRQ is 1.120. The company is able to pay all its debts with equity. +1
  • The TTM is 1.177. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.120TTM1.177-0.056
TTM1.177YOY1.256-0.079
TTM1.1775Y1.584-0.407
5Y1.58410Y1.416+0.168
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1200.390+0.730
TTM1.1770.408+0.769
YOY1.2560.341+0.915
5Y1.5840.438+1.146
10Y1.4160.469+0.947

2. Market Valuation of Genoway

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Genoway generates.

  • Above 15 is considered overpriced but always compare Genoway to the Biotechnology industry mean.
  • A PE ratio of 18.48 means the investor is paying €18.48 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Genoway:

  • The EOD is 16.712. Based on the earnings, the company is fair priced.
  • The MRQ is 18.480. Based on the earnings, the company is fair priced.
  • The TTM is 17.185. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD16.712MRQ18.480-1.768
MRQ18.480TTM17.185+1.295
TTM17.185YOY54.251-37.067
TTM17.1855Y63.462-46.277
5Y63.46210Y146.473-83.011
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD16.712-2.351+19.063
MRQ18.480-2.599+21.079
TTM17.185-2.762+19.947
YOY54.251-4.025+58.276
5Y63.462-6.305+69.767
10Y146.473-6.538+153.011
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Genoway:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-10.662+10.662
TTM-10.662YOY5.488-16.150
TTM-10.6625Y2.974-13.636
5Y2.97410Y-0.983+3.957
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--3.306+3.306
TTM-10.662-3.607-7.055
YOY5.488-5.524+11.012
5Y2.974-8.299+11.273
10Y-0.983-8.910+7.927
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Genoway is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 2.56 means the investor is paying €2.56 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Genoway:

  • The EOD is 2.316. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.561. Based on the equity, the company is underpriced. +1
  • The TTM is 2.306. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.316MRQ2.561-0.245
MRQ2.561TTM2.306+0.256
TTM2.306YOY2.106+0.199
TTM2.3065Y2.239+0.066
5Y2.23910Y2.587-0.348
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.3162.019+0.297
MRQ2.5612.116+0.445
TTM2.3062.099+0.207
YOY2.1062.873-0.767
5Y2.2393.556-1.317
10Y2.5873.946-1.359
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Genoway compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.030-100%0.010-100%0.046-100%0.033-100%
Book Value Per Share--1.7961.766+2%1.681+7%1.319+36%1.006+78%
Current Ratio---1.518-100%2.339-100%1.941-100%1.604-100%
Debt To Asset Ratio--0.5090.519-2%0.540-6%0.597-15%0.575-12%
Debt To Equity Ratio--1.1201.177-5%1.256-11%1.584-29%1.416-21%
Dividend Per Share----0%-0%-0%-0%
Eps--0.0620.059+5%0.027+132%0.000+16098%0.011+460%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap34023475.200-20%40663471.00035998404.415+13%31223126.043+30%25399397.931+60%20726564.494+96%
Net Profit Margin--0.0510.053-4%0.029+75%-0.011+121%0.021+142%
Operating Margin---0.666-0.254-62%-0.092-86%-0.073-89%-0.036-95%
Operating Ratio--1.6610.919+81%0.758+119%0.366+354%0.556+199%
Pb Ratio2.316-11%2.5612.306+11%2.106+22%2.239+14%2.587-1%
Pe Ratio16.712-11%18.48017.185+8%54.251-66%63.462-71%146.473-87%
Price Per Share4.160-11%4.6004.075+13%3.545+30%2.987+54%2.478+86%
Price To Free Cash Flow Ratio----10.6620%5.488-100%2.974-100%-0.9830%
Quick Ratio---1.288-100%1.908-100%1.482-100%1.244-100%
Return On Assets--0.0170.021-20%0.009+88%0.000+100%0.005+246%
Return On Equity--0.0370.048-22%0.021+75%-0.003+109%0.010+278%
Total Gains Per Share---0.030-100%0.010-100%0.046-100%0.033-100%
Usd Book Value--17037964.36616739026.653+2%15891851.516+7%12040734.548+42%9051846.092+88%
Usd Book Value Change Per Share---0.032-100%0.011-100%0.050-100%0.035-100%
Usd Book Value Per Share--1.9271.895+2%1.804+7%1.416+36%1.080+78%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps--0.0670.063+5%0.029+132%0.000+16098%0.012+460%
Usd Free Cash Flow----588075.6800%1682017.059-100%-257688.5560%-824271.2670%
Usd Market Cap36513993.585-20%43640037.07738633487.618+13%33508658.870+30%27258633.860+60%22243749.015+96%
Usd Price Per Share4.465-11%4.9374.373+13%3.804+30%3.206+54%2.660+86%
Usd Profit--590380.198742991.743-21%314135.657+88%55795.906+958%99857.158+491%
Usd Revenue--11498689.7877171122.400+60%6100492.714+88%4311273.290+167%3439611.945+234%
Usd Total Gains Per Share---0.032-100%0.011-100%0.050-100%0.035-100%
 EOD+3 -3MRQTTM+11 -15YOY+17 -115Y+17 -1010Y+17 -9

3.2. Fundamental Score

Let's check the fundamental score of Genoway based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1516.712
Price to Book Ratio (EOD)Between0-12.316
Net Profit Margin (MRQ)Greater than00.051
Operating Margin (MRQ)Greater than0-0.666
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.000
Debt to Asset Ratio (MRQ)Less than10.509
Debt to Equity Ratio (MRQ)Less than11.120
Return on Equity (MRQ)Greater than0.150.037
Return on Assets (MRQ)Greater than0.050.017
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Genoway based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.889
Ma 20Greater thanMa 504.042
Ma 50Greater thanMa 1004.012
Ma 100Greater thanMa 2004.183
OpenGreater thanClose4.160
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
 As reported
Total Liabilities 0
Total Stockholder Equity+ 0
Total Assets = 0

Assets

Total Current Assets
Total Current Assets  (as reported)0
Total Current Assets  (calculated)0
+/-0
Long-term Assets
Long-term Assets  (as reported)0
Long-term Assets  (calculated)0
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities
Total Current Liabilities  (as reported)0
Total Current Liabilities  (calculated)0
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Total Stockholder Equity (as reported)0
Total Stockholder Equity (calculated)0
+/-0
Other
Common Stock Shares Outstanding 8,840



Balance Sheet

All numbers in thousands.

 Trend2023-12-312023-06-302023-03-312022-12-312022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312005-12-312004-12-31
> Total Assets 
5,411
4,404
7,078
11,339
11,339
10,292
10,292
8,476
8,476
10,227
10,227
0
10,204
11,170
11,170
0
10,628
11,430
11,430
11,932
11,932
11,007
11,007
11,086
11,086
10,538
10,538
10,250
10,250
9,747
9,747
10,168
10,168
10,376
10,376
9,854
9,854
10,775
10,755
10,964
10,964
11,700
11,700
16,904
16,903
17,167
17,167
18,385
18,385
19,688
19,688
19,318
19,318
0
19,153
0
25,023
0
27,569
0
30,546
0
32,660
0
31,280
32,598
0
32,323
0
032,323032,59831,280032,660030,546027,569025,023019,153019,31819,31819,68819,68818,38518,38517,16717,16716,90316,90411,70011,70010,96410,96410,75510,7759,8549,85410,37610,37610,16810,1689,7479,74710,25010,25010,53810,53811,08611,08611,00711,00711,93211,93211,43011,43010,628011,17011,17010,204010,22710,2278,4768,47610,29210,29211,33911,3397,0784,4045,411
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
8,891
0
10,109
0
9,399
0
10,218
0
10,812
0
9,704
0
9,937
0
9,229
0
9,082
0
8,709
0
8,350
0
8,628
0
8,275
0
9,225
0
9,518
10,269
10,269
11,445
11,445
10,577
10,577
10,257
10,257
10,212
10,212
9,640
9,640
9,766
9,766
14,913
14,913
14,516
14,516
17,494
17,494
19,329
19,329
18,040
18,040
19,823
20,047
20,047
0
020,04720,04719,82318,04018,04019,32919,32917,49417,49414,51614,51614,91314,9139,7669,7669,6409,64010,21210,21210,25710,25710,57710,57711,44511,44510,26910,2699,51809,22508,27508,62808,35008,70909,08209,22909,93709,704010,812010,21809,399010,10908,891000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
4,038
0
4,573
0
5,177
0
5,570
0
5,868
0
6,115
0
5,312
0
4,015
0
4,047
0
4,548
0
3,679
0
3,814
0
2,928
0
3,788
0
2,371
2,643
2,643
2,356
2,356
3,945
3,945
1,509
1,509
3,050
3,050
541
541
0
1,086
0
7,380
0
2,720
0
2,746
0
5,605
0
6,006
4,880
0
2,814
0
02,81404,8806,00605,60502,74602,72007,38001,08605415413,0503,0501,5091,5093,9453,9452,3562,3562,6432,6432,37103,78802,92803,81403,67904,54804,04704,01505,31206,11505,86805,57005,17704,57304,038000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
200
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
1
0
1
0
1
0
1
0
1
0
1
1
1
1
1
1
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-36
-36
0
-36
0
0-360-36-36000000000000000111111111010101010101000000000000020000000000000000
       Net Receivables 
1,452
1,816
3,677
3,806
3,806
3,289
3,289
3,902
3,902
5,138
5,138
0
0
4,365
4,365
0
0
3,699
3,699
3,842
3,842
2,605
2,605
3,198
3,198
4,205
4,205
4,296
4,296
3,538
3,538
4,070
4,070
4,195
4,195
4,755
4,755
4,747
4,747
6,313
6,313
6,559
6,559
7,818
7,818
5,971
5,971
8,030
8,030
6,493
6,493
8,321
3,095
7,865
7,865
6,517
6,517
10,499
10,499
12,973
12,973
12,497
6,359
10,847
10,793
13,587
15,656
15,633
0
015,63315,65613,58710,79310,8476,35912,49712,97312,97310,49910,4996,5176,5177,8657,8653,0958,3216,4936,4938,0308,0305,9715,9717,8187,8186,5596,5596,3136,3134,7474,7474,7554,7554,1954,1954,0704,0703,5383,5384,2964,2964,2054,2053,1983,1982,6052,6053,8423,8423,6993,699004,3654,365005,1385,1383,9023,9023,2893,2893,8063,8063,6771,8161,452
       Inventory 
134
140
375
415
415
586
586
881
881
401
401
0
497
374
374
0
544
676
676
824
824
760
760
845
845
787
787
542
542
354
354
358
358
319
319
262
262
425
425
514
514
738
738
978
978
469
469
504
504
544
544
656
656
676
676
925
925
1,162
1,162
1,335
1,335
979
979
954
1,008
1,185
1,337
1,359
0
01,3591,3371,1851,0089549799791,3351,3351,1621,16292592567667665665654454450450446946997897873873851451442542526226231931935835835435454254278778784584576076082482467667654403743744970401401881881586586415415375140134
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
1,313
0
1,061
0
1,229
0
1,212
0
1,120
0
1,304
0
1,149
0
1,309
0
1,167
0
1,039
0
1,818
0
1,749
0
1,580
0
1,530
0
1,446
0
1,431
0
5,458
0
6,343
0
8,127
0
9,476
0
9,678
0
9,386
0
10,110
0
13,053
0
13,052
0
13,331
0
13,240
12,775
0
12,276
0
012,276012,77513,240013,331013,052013,053010,11009,38609,67809,47608,12706,34305,45801,43101,44601,53001,58001,74901,81801,03901,16701,30901,14901,30401,12001,21201,22901,06101,313000000000000
       Property Plant Equipment 
354
286
265
387
387
500
500
356
356
810
810
0
743
665
665
0
853
858
858
788
788
711
711
636
636
564
564
515
515
498
498
434
434
395
395
356
356
412
412
421
421
483
483
4,499
4,499
5,631
5,631
6,290
6,290
6,253
6,253
6,085
6,085
5,826
5,826
5,996
5,996
7,873
7,873
7,515
7,515
7,169
7,169
7,085
7,085
6,667
6,228
6,228
0
06,2286,2286,6677,0857,0857,1697,1697,5157,5157,8737,8735,9965,9965,8265,8266,0856,0856,2536,2536,2906,2905,6315,6314,4994,49948348342142141241235635639539543443449849851551556456463663671171178878885885885306656657430810810356356500500387387265286354
       Goodwill 
158
158
197
197
197
197
197
197
197
197
197
0
197
197
197
0
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
197
0
197
0
197
0
197
0
197
0
197
0
197
197
0
197
0
0197019719701970197019701970197019719719719719719719719719719719719719719719719719719719719719719719719719719719719719719719719719719719719719701971971970197197197197197197197197197158158
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53
53
215
215
226
226
593
593
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000593593226226215215535300000000000000000000000000000000000000000
       Intangible Assets 
214
200
450
222
222
288
288
283
283
562
562
0
307
330
133
0
113
288
91
266
69
454
454
391
391
617
617
516
516
411
411
1,236
1,236
1,158
1,158
1,022
1,022
929
929
845
845
763
566
680
483
606
409
646
646
2,526
2,526
2,920
2,920
0
2,943
0
3,253
0
4,186
0
4,586
0
5,249
0
5,601
5,333
0
5,460
0
05,46005,3335,60105,24904,58604,18603,25302,94302,9202,9202,5262,5266466464096064836805667638458459299291,0221,0221,1581,1581,2361,236411411516516617617391391454454692669128811301333303070562562283283288288222222450200214
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
66
0
200
0
66
0
66
0
66
0
138
0
-513
0
127
0
1
0
1
0
1
0
1
0
1
0
-19
0
1
0
1
0
65
0
129
0
155
0
500
0
477
0
421
0
663
0
797
0
753
0
716
0
-12,686
-12,197
0
-11,688
0
0-11,6880-12,197-12,68607160753079706630421047705000155012906501010-19010101010101270-51301380660660660200066000000000000
> Total Liabilities 
3,514
5,973
6,974
6,665
6,665
5,729
5,729
4,640
4,640
6,828
6,828
0
5,734
7,346
7,346
0
6,683
6,833
6,833
7,090
7,090
5,776
6,428
6,261
6,914
5,700
6,311
5,247
5,917
4,752
5,259
4,998
4,998
5,231
5,231
5,142
5,142
6,098
6,078
6,106
6,106
6,441
6,441
10,042
10,042
9,977
9,977
10,870
10,870
11,798
11,796
12,474
12,472
0
12,310
0
17,310
0
18,572
0
16,359
0
17,940
0
16,617
17,557
0
16,447
0
016,447017,55716,617017,940016,359018,572017,310012,310012,47212,47411,79611,79810,87010,8709,9779,97710,04210,0426,4416,4416,1066,1066,0786,0985,1425,1425,2315,2314,9984,9985,2594,7525,9175,2476,3115,7006,9146,2616,4285,7767,0907,0906,8336,8336,68307,3467,3465,73406,8286,8284,6404,6405,7295,7296,6656,6656,9745,9733,514
   > Total Current Liabilities 
1,953
1,174
1,701
2,292
2,292
4,552
4,552
2,017
2,017
5,421
3,822
0
5,486
7,206
7,206
0
6,373
6,569
6,569
6,881
6,881
5,668
5,668
6,153
6,153
5,589
5,589
5,139
5,139
4,644
4,644
4,890
3,606
5,112
5,112
4,986
4,986
5,952
5,952
5,988
5,988
6,149
6,168
6,304
6,115
6,271
5,830
5,924
5,924
5,969
6,714
6,397
6,397
6,594
6,594
6,588
6,588
7,940
7,940
7,712
7,712
8,280
8,280
7,423
7,704
8,833
8,724
8,891
0
08,8918,7248,8337,7047,4238,2808,2807,7127,7127,9407,9406,5886,5886,5946,5946,3976,3976,7145,9695,9245,9245,8306,2716,1156,3046,1686,1495,9885,9885,9525,9524,9864,9865,1125,1123,6064,8904,6444,6445,1395,1395,5895,5896,1536,1535,6685,6686,8816,8816,5696,5696,37307,2067,2065,48603,8225,4212,0172,0174,5524,5522,2922,2921,7011,1741,953
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
42
0
5
0
7
0
8
0
6
0
4
0
6
0
38
0
8
0
6
0
71
0
226
0
10
0
26
0
47
11
11
3,597
7
441
11
258
274
347
7
744
750
0
751
0
691
0
751
0
1,436
0
1,831
0
1,600
1,846
0
2,086
0
02,08601,8461,60001,83101,436075106910751075074473472742581144173,59711114702601002260710608038060406080705042000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11
11
3,597
3,597
441
441
258
258
347
347
744
750
0
751
0
691
0
751
0
1,436
0
1,831
0
1,600
7
0
2,086
0
02,086071,60001,83101,43607510691075107507443473472582584414413,5973,597111100000000000000000000000000000000000000000
       Accounts payable 
1,006
601
944
1,331
1,331
1,331
1,331
1,085
1,085
1,282
1,282
0
0
1,760
1,760
0
0
1,115
1,115
1,927
1,927
1,248
1,248
2,011
2,011
1,290
1,290
984
984
630
630
854
854
924
924
949
949
1,097
1,097
1,495
1,495
1,407
1,407
1,327
1,327
772
772
1,203
1,203
2,247
2,247
2,575
2,575
2,392
2,392
1,871
1,871
2,288
2,288
2,741
2,741
2,216
2,216
1,748
1,748
2,616
2,585
2,585
0
02,5852,5852,6161,7481,7482,2162,2162,7412,7412,2882,2881,8711,8712,3922,3922,5752,5752,2472,2471,2031,2037727721,3271,3271,4071,4071,4951,4951,0971,0979499499249248548546306309849841,2901,2902,0112,0111,2481,2481,9271,9271,1151,115001,7601,760001,2821,2821,0851,0851,3311,3311,3311,3319446011,006
       Other Current Liabilities 
944
542
719
913
913
2,962
2,962
927
927
4,136
2,536
0
0
5,443
5,443
0
0
5,446
5,446
4,948
4,948
4,415
4,415
4,136
4,136
4,261
4,261
4,148
4,148
4,007
4,007
3,965
3,965
3,983
3,983
4,027
4,027
4,844
4,844
4,483
4,483
4,731
4,731
4,781
4,781
5,047
5,047
3,013
3,013
1,913
1,913
1,707
1,557
2,143
3,452
2,718
4,026
3,321
4,901
1,829
796
2,362
1,199
2,375
2,473
2,461
2,173
2,513
0
02,5132,1732,4612,4732,3751,1992,3627961,8294,9013,3214,0262,7183,4522,1431,5571,7071,9131,9133,0133,0135,0475,0474,7814,7814,7314,7314,4834,4834,8444,8444,0274,0273,9833,9833,9653,9654,0074,0074,1484,1484,2614,2614,1364,1364,4154,4154,9484,9485,4465,446005,4435,443002,5364,1369279272,9622,962913913719542944
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
248
0
140
0
310
0
264
0
209
0
761
0
761
0
722
0
778
0
615
0
1,392
0
118
0
156
0
126
0
118
0
273
0
3,927
0
4,147
0
4,946
0
5,082
0
6,075
0
5,717
0
10,722
0
10,631
0
8,647
0
9,660
0
8,912
8,725
0
7,556
0
07,55608,7258,91209,66008,647010,631010,72205,71706,07505,08204,94604,14703,9270273011801260156011801,3920615077807220761076102090264031001400248000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,264
0
10,268
0
10,014
0
7,951
0
8,995
0
8,333
7,200
0
6,048
0
06,04807,2008,33308,99507,951010,014010,26805,264000000000000000000000000000000000000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
955
0
0
0
0
0
114
0
244
0
240
0
282
136
0
167
0
01670136282024002440114000009550000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
1,898
0
104
4,674
4,674
4,564
4,564
3,836
3,836
3,399
3,399
3,399
0
3,824
3,824
3,824
0
4,597
4,597
4,842
4,842
5,232
5,232
4,825
4,825
4,838
4,838
5,002
5,002
4,995
4,995
5,170
5,170
5,146
5,146
4,712
4,712
4,677
4,677
4,857
4,857
5,259
5,259
6,862
6,862
7,191
7,191
7,515
7,515
7,890
7,890
6,845
6,846
0
6,842
0
7,712
0
8,997
0
14,187
0
14,720
0
13,196
13,614
0
14,681
0
014,681013,61413,196014,720014,18708,99707,71206,84206,8466,8457,8907,8907,5157,5157,1917,1916,8626,8625,2595,2594,8574,8574,6774,6774,7124,7125,1465,1465,1705,1704,9954,9955,0025,0024,8384,8384,8254,8255,2325,2324,8424,8424,5974,59703,8243,8243,82403,3993,3993,3993,8363,8364,5644,5644,6744,67410401,898
   Common Stock
429
429
650
842
842
852
852
852
852
852
852
0
0
886
886
0
0
886
886
886
886
886
886
886
886
886
886
886
886
886
886
898
898
898
898
898
898
898
898
898
898
898
898
898
898
898
898
3,594
3,594
3,594
3,594
3,594
3,594
3,590
3,590
4,228
4,228
4,228
4,228
5,084
5,084
5,452
5,452
5,629
5,629
5,452
5,471
5,471
0
05,4715,4715,4525,6295,6295,4525,4525,0845,0844,2284,2284,2284,2283,5903,5903,5943,5943,5943,5943,5943,5948988988988988988988988988988988988988988988988988868868868868868868868868868868868868868860088688600852852852852852852842842650429429
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 0-2890-299-14000000-3,1890-2,8390-2,5340-2,2280-1,9260-1,6020-1,3560-1,5140-1,4220-1,3400-1,2680-1,1920-1,1240-1,0480-1,1300-1,0570-9980-9060-8110-7140-6390-558000-507000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,750
0
4,791
0
4,793
0
9,585
0
9,218
0
9,041
9,218
0
9,238
0
09,23809,2189,04109,21809,58504,79304,79103,750000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
124
124
124
5,987
117
6,310
7
7,807
1,162
9,171
1,379
10,991
1,558
10,802
1,618
9,041
9,218
2,124
9,238
0
09,2382,1249,2189,0411,61810,8021,55810,9911,3799,1711,1627,80776,3101175,9871241241240000000000000000000000000000000000000000000000000



Balance Sheet

All numbers in thousands.




Cash Flow

All numbers in thousands.




Income Statement

All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue20,046
Cost of Revenue--54
Gross Profit20,10020,100
 
Operating Income (+$)
Gross Profit20,100
Operating Expense-17,981
Operating Income2,0652,119
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense17,9810
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income2,065
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,9584,130
EBIT - interestExpense = 2,065
1,958
1,568
Interest Expense0
Earnings Before Interest and Taxes (EBIT)2,0651,958
Earnings Before Interest and Taxes (EBITDA)20,100
 
After tax Income (+$)
Income Before Tax1,958
Tax Provision-0
Net Income From Continuing Ops01,958
Net Income1,568
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses17,981
Total Other Income/Expenses Net-2,0650
 

Technical Analysis of Genoway
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Genoway. The general trend of Genoway is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Genoway's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Genoway.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.46 < 4.47 < 4.91.

The bearish price targets are: 3.81 > 3.72 > 3.51.

Tweet this
Genoway Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Genoway. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Genoway Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Genoway. The current macd is 0.01542237.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Genoway price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Genoway. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Genoway price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Genoway Daily Moving Average Convergence/Divergence (MACD) ChartGenoway Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Genoway. The current adx is 17.94.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Genoway shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Genoway Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Genoway. The current sar is 3.84973984.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Genoway Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Genoway. The current rsi is 60.89. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 3/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
Genoway Daily Relative Strength Index (RSI) ChartGenoway Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Genoway. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Genoway price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Genoway Daily Stochastic Oscillator ChartGenoway Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Genoway. The current cci is 104.87.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Genoway Daily Commodity Channel Index (CCI) ChartGenoway Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Genoway. The current cmo is 38.87.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Genoway Daily Chande Momentum Oscillator (CMO) ChartGenoway Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Genoway. The current willr is -7.89473684.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Genoway Daily Williams %R ChartGenoway Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Genoway.

Genoway Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Genoway. The current atr is 0.11135561.

Genoway Daily Average True Range (ATR) ChartGenoway Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Genoway. The current obv is 305,890.

Genoway Daily On-Balance Volume (OBV) ChartGenoway Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Genoway. The current mfi is 80.08.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Genoway Daily Money Flow Index (MFI) ChartGenoway Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Genoway.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-27WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-20STOCH LONG EXITThe %K line crosses below the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside

6.3. Candlestick Patterns

Genoway Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Genoway based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5060.889
Ma 20Greater thanMa 504.042
Ma 50Greater thanMa 1004.012
Ma 100Greater thanMa 2004.183
OpenGreater thanClose4.160
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Genoway with someone you think should read this too:
  • Are you bullish or bearish on Genoway? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Genoway? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Genoway

I send you an email if I find something interesting about Genoway.


Comments

How you think about this?

Leave a comment

Stay informed about Genoway.

Receive notifications about Genoway in your mailbox!